BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Biotech Beach

  ALSP, Inc. Invited To Give Oral Presentation At The Keystone TBI Conference January 25-27 In Santa Fe, NM. (Abstracts Of Two Presentations Will Be Posted On Company’s Website)

  January 25, 2016

   · 

  2 min read
• BioCapital

  CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine

  January 25, 2016

   · 

  1 min read
• Business

  Broad Institute Genomic Services Partners With Takeda To Offer Genomic Insight Into The Recently Approved Therapeutic NINLARO (ixazomib)

  January 25, 2016

   · 

  4 min read
• Drug Development

  Shire Resubmits New Drug Application For Lifitegrast To U.S. FDA

  January 25, 2016

   · 

  10 min read
• Business

  Landauer Announces Date And Time For Announcement Of Fiscal First Quarter 2016 Results And Conference Call

  January 25, 2016

   · 

  2 min read
• Drug Development

  Valeant Announces FDA Acceptance Of BLA Submission For Brodalumab In Moderate-To-Severe Plaque Psoriasis

  January 25, 2016

   · 

  3 min read
• BioMidwest

  InfuSystem Holdings, Inc. EXPRESS Integrates With The Cerner System At The University of Missouris Ellis Fischel Cancer Center

  January 25, 2016

   · 

  4 min read
• BioMidwest

  EnteroMedics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

  January 25, 2016

   · 

  4 min read
• Drug Development

  Milestone Pharmaceuticals Announces USAN Approval Of Generic Name “Etripamil” For Its Phase 2 Clinical Development Product For The Treatment Of Paroxysmal Supraventricular Tachycardia

  January 25, 2016

   · 

  2 min read
• Drug Development

  Boston Biomedical’s Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured At The ASCO 2016 Gastrointestinal Cancers Symposium

  January 25, 2016

   · 

  6 min read